Mutagenicity evaluation of methyl tertiary- butyl ether in multiple tissues of transgenic rats following whole body inhalation exposure
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Methyl tertiary-butyl ether (MTBE) is not a mutagen in vivo. Studies show MTBE exposure did not increase mutations in key rat tissues, suggesting kidney tumors are not caused by mutagenicity.
Area Of Science
- Toxicology
- Genetics
- Environmental Health
Background
- Methyl tertiary-butyl ether (MTBE) is a fuel additive used to improve combustion and reduce emissions.
- Concerns regarding MTBE's mutagenic potential arose from conflicting genotoxicity data and tumor observations in rat bioassays.
Purpose Of The Study
- To investigate the in vivo mutagenic potential of MTBE.
- To determine if MTBE exposure induces mutations in critical rat tissues.
Main Methods
- Transgenic male Big Blue Fischer 344 rats were exposed to MTBE (0, 400, 1000, 3000 ppm) via inhalation for 28 days.
- Mutant frequencies (MF) were analyzed in the nasal epithelium, liver, bone marrow, and kidney.
- Experimental validity was confirmed using ethyl nitrosourea as a positive control.
Main Results
- MTBE exposure did not result in a mutagenic response in any of the analyzed tissues.
- No significant increase in mutant frequencies was observed in the nasal epithelium, liver, bone marrow, or kidney.
Conclusions
- MTBE is not an in vivo mutagen.
- The observed kidney tumors in male rats are unlikely to be a result of a mutagenic mechanism of action.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
